$147 Million is the total value of Nan Fung Group Holdings Ltd's 44 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 80.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| New | OCULIS HOLDING AGordinary shares | $4,837,673 | – | 651,100 | +100.0% | 3.29% | – | |
| Buy | EXSCIENTIA PLCads | $4,557,428 | +0.2% | 859,892 | +0.8% | 3.10% | -1.0% | |
| MRUS | Buy | MERUS N V | $2,778,400 | +91.6% | 151,000 | +61.1% | 1.89% | +89.3% |
| Buy | GITLAB INC | $1,267,084 | +303.5% | 36,952 | +434.8% | 0.86% | +299.1% | |
| MELI | New | MERCADOLIBRE INC | $1,191,526 | – | 904 | +100.0% | 0.81% | – |
| BMRN | Buy | BIOMARIN PHARMACEUTICAL INC | $701,587 | +10.9% | 7,215 | +18.0% | 0.48% | +9.4% |
| New | EARGO INC | $692,191 | – | 147,904 | +100.0% | 0.47% | – | |
| ARGX | Buy | ARGENX SEsponsored adr | $532,789 | +26.7% | 1,430 | +28.8% | 0.36% | +25.2% |
| BCRX | New | BIOCRYST PHARMACEUTICALS INC | $148,844 | – | 17,847 | +100.0% | 0.10% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-05-12
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| KARUNA THERAPEUTICS INC | 10 | Q3 2023 | 34.7% |
| HARMONY BIOSCIENCES HLDGS IN | 10 | Q3 2023 | 21.3% |
| XENON PHARMACEUTICALS INC | 10 | Q3 2023 | 3.1% |
| BOLT BIOTHERAPEUTICS INC | 10 | Q3 2023 | 5.6% |
| GALERA THERAPEUTICS INC | 10 | Q3 2023 | 1.9% |
| KALVISTA PHARMACEUTICALS INC | 10 | Q3 2023 | 1.8% |
| EXELIXIS INC | 10 | Q3 2023 | 1.1% |
| DBV TECHNOLOGIES S A | 10 | Q3 2023 | 0.6% |
| ALX ONCOLOGY HLDGS INC | 10 | Q3 2023 | 1.0% |
| ILLUMINA INC | 9 | Q3 2023 | 21.5% |
View Nan Fung Group Holdings Ltd's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Eargo, Inc. | December 16, 2022 | 2,958,099 | 0.7% |
| Stealth BioTherapeutics Corp | January 09, 2020 | 20,240,817 | 4.8% |
| New Frontier Health Corp | January 02, 2020 | 9,650,000 | 7.3% |
View Nan Fung Group Holdings Ltd's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-13 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-13 |
| SC 13D/A | 2022-12-16 |
| 13F-HR | 2022-11-10 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-14 |
View Nan Fung Group Holdings Ltd's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.